Shattuck Labs (STTK) Shares Outstanding (Weighted Average) (2019 - 2026)

Shattuck Labs (STTK) reported Shares Outstanding (Weighted Average) of $38.4 million for Q1 2026, down 24.56% year-over-year from $51.0 million in Q1 2025, and down 44.75% quarter-over-quarter from $69.6 million in Q4 2025.

Shattuck Labs (STTK) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $38.4 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $38.4 million, down 24.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.4 million (down 24.56% YoY), and the FY2025 annual result was $69.6 million, up 37.09% from the prior year.
  • Shares Outstanding (Weighted Average) eased to $38.4 million in Q1 2026 per STTK's latest filing, from $69.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $72.2 million in Q3 2025 and troughed at $3.1 million in Q4 2023.
  • A 5-year average of $43.4 million and a median of $42.5 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) plunged 92.7% in 2024, then surged 1544.21% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.4 million in 2022, then sank by 92.68% to $3.1 million in 2023, then soared by 1536.93% to $50.8 million in 2024, then jumped by 37.09% to $69.6 million in 2025, then sank by 44.75% to $38.4 million in 2026.
  • Business Quant data shows STTK's Shares Outstanding (Weighted Average) at $38.4 million in Q1 2026, $69.6 million in Q4 2025, and $72.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Shattuck Labs 190.32 Mn 190.32 Mn - 38.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.45 Mn
Dec 31, 2025 69.58 Mn
Sep 30, 2025 72.18 Mn
Jun 30, 2025 50.98 Mn
Mar 31, 2025 50.97 Mn
Dec 31, 2024 50.76 Mn
Sep 30, 2024 50.73 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 50.57 Mn
Dec 31, 2023 3.10 Mn
Sep 30, 2023 42.48 Mn
Jun 30, 2023 42.45 Mn
Mar 31, 2023 42.44 Mn
Dec 31, 2022 42.38 Mn
Sep 30, 2022 42.37 Mn
Jun 30, 2022 42.38 Mn
Mar 31, 2022 42.36 Mn
Dec 31, 2021 42.03 Mn
Sep 30, 2021 41.95 Mn
Jun 30, 2021 41.84 Mn